Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Multiple Myeloma × Warfarin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Venous Thrombosis 2 Venous Thromboembolism 2 Thrombosis 2 Pulmonary Embolism 2 Urinary Tract Infections 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thromboembolism 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Prostatic Neoplasms 1 Pneumonia 1 Pancreatic Neoplasms 1 Pain 1 Neutropenia 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Intraabdominal Infections 1

Interventions

Dexamethasone 379 Lenalidomide 237 Cyclophosphamide 223 Bortezomib 212 Melphalan 176 Calcium Dobesilate 149 fludarabine phosphate 95 daratumumab 93 Peripheral Blood Stem Cell Transplantation 89 carfilzomib 80 Filgrastim 80 Thalidomide 77 Whole-Body Irradiation 74 pomalidomide 73 fludarabine 73 Mycophenolic Acid 69 Busulfan 63 Tacrolimus 59 Granulocyte Colony-Stimulating Factor 59 ixazomib 52 dexamethasone acetate 52 Cyclosporine 52 dexamethasone 21-phosphate 45 Antilymphocyte Serum 45 auricularum 41 Etoposide 35 Radiotherapy 34 Stem Cell Transplantation 33 isatuximab 30 Bendamustine Hydrochloride 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00790842 2018-10-24

PrE1003

PrECOG, LLC.

Phase 1/2 Terminated

63 enrolled 14 charts

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡